Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
283.54
+5.14 (1.85%)
At close: May 29, 2025, 4:00 PM
283.09
-0.45 (-0.16%)
After-hours: May 29, 2025, 7:57 PM EDT
Amgen Market Cap
Amgen has a market cap or net worth of $152.46 billion as of May 29, 2025. Its market cap has decreased by -8.36% in one year.
Market Cap
152.46B
Enterprise Value
201.03B
1-Year Change
-8.36%
Ranking
Category
Stock Price
$283.54
Market Cap Chart
Since December 1, 1998, Amgen's market cap has increased from $19.50B to $152.46B, an increase of 681.74%. That is a compound annual growth rate of 8.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 28, 2025 | 149.70B | 6.85% |
Dec 31, 2024 | 140.10B | -9.11% |
Dec 29, 2023 | 154.14B | 9.99% |
Dec 30, 2022 | 140.14B | 10.59% |
Dec 31, 2021 | 126.72B | -5.33% |
Dec 31, 2020 | 133.85B | -6.55% |
Dec 31, 2019 | 143.24B | 15.47% |
Dec 31, 2018 | 124.05B | -1.73% |
Dec 29, 2017 | 126.24B | 16.06% |
Dec 30, 2016 | 108.77B | -11.17% |
Dec 31, 2015 | 122.45B | 1.06% |
Dec 31, 2014 | 121.17B | 40.84% |
Dec 31, 2013 | 86.03B | 30.06% |
Dec 31, 2012 | 66.15B | 17.52% |
Dec 30, 2011 | 56.28B | 8.51% |
Dec 31, 2010 | 51.87B | -9.41% |
Dec 31, 2009 | 57.26B | -6.42% |
Dec 31, 2008 | 61.19B | 21.14% |
Dec 31, 2007 | 50.51B | -36.61% |
Dec 29, 2006 | 79.68B | -18.14% |
Dec 30, 2005 | 97.34B | 19.46% |
Dec 31, 2004 | 81.48B | 2.22% |
Dec 31, 2003 | 79.71B | 28.11% |
Dec 31, 2002 | 62.22B | 5.44% |
Dec 31, 2001 | 59.01B | -10.66% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 646.37B |
Johnson & Johnson | 369.21B |
AbbVie | 327.77B |
Novo Nordisk | 305.07B |
UnitedHealth Group | 269.94B |
Abbott Laboratories | 231.21B |
Novartis AG | 219.70B |
AstraZeneca | 216.88B |